Solid organ transplant outcomes
Children’s Medical Center Dallas received a 4 of 5 rating from the SRTR January 2018 Program Specific Report for our Liver Transplant outcomes. This rating indicates our transplant program, led by UT Southwestern surgeons and physicians, consistently achieves outcomes that meet or exceed the national average. We are proud of the clinical expertise and dedication to patient centered care that these results are built on.
Heart, Kidney, Liver – 1-Year Survival Rates
Graphs compiled using data from the Scientific Registry of Transplant Recipients
January 2018 Program Specific Report*
Observed | Expected | National | |
Heart 1-Year Patient | 98% | 94% | 94% |
Heart 1-Year Organ | 98% | 94% | 94% |
Kidney 1-Year Patient | 100% | 100% | 100% |
Kidney 1-Year Organ | 89% | 98% | 98% |
Liver 1-Year Patient | 100% | 94% | 95% |
Liver 1-Year Organ | 96% | 91% | 92% |
We encourage you to visit www.srtr.org to obtain detailed information and reports however, the following are the current observed survival rates (outcomes) for our Solid Organ Transplant programs compared to expected and national rates.
Graph Definitions:
- Observed – Results actually observed at Children’s Health℠
- Expected – “Risk-adjusted” results that the SRTR has determined our results “should” be given our patient populations variables as age, service area, underlying diseases, etc.
- National Observed – The average survival for all pediatric transplant centers in the United States.
-
Heart Outcomes – 1-year Survival Rates
Graphs compiled using data from the Scientific Registry of Transplant Recipients
January 2018 Program Specific Report*Observed Expected National Heart 1-Year Patient 98% 94% 94% Heart 1-Year Organ 98% 94% 94% -
Kidney Outcomes – 1-year Survival Rates
Please note that for kidney, there are no expected outcomes due to the small sample sizes for the time period.
Graphs compiled using data from the Scientific Registry of Transplant Recipients
January 2018 Program Specific Report*Observed Expected National Kidney 1-Year Patient 100% 100% 100% Kidney 1-Year Organ 89% 98% 98% -
Liver Outcomes – 1-year Survival Rates
Graphs compiled using data from the Scientific Registry of Transplant Recipients
January 2018 Program Specific Report*Observed Expected National Liver 1-Year Patient 100% 94% 95% Liver 1-Year Organ 96% 91% 92%
If you have any questions, concerns or comments please feel free to speak with your coordinator, physician or any member of the transplant administrative team.
Access the Scientific Registry of Transplant Recipients for comprehensive outcomes information.
Contact Transplant
Phone: 800-846-6768
Transplant survival statistics are an important way to communicate a program’s accomplishments. In fact, government regulations require transplant programs to share current organ and patient survival statistics at the time a patient undergoes evaluation. Guidelines established by Centers for Medicare and Medicaid (CMS) require transplant programs to make the most current statistics available to their waitlisted patients.
The National Organ Transplant Act (NOTA) of 1984 established the Scientific Registry for Transplant Recipients (SRTR) under direction of the Organ Procurement and Transplant Network (OPTN). The SRTR is responsible for collecting and managing the data for the OPTN and provides periodic reports to the transplant community and the general public. Transplant program survival statistics are updated by the SRTR twice a year, in January and July. Below is a description of the SRTR taken directly from their website, www.srtr.org, to help explain the purpose of the data and statistics.
The Scientific Registry of Transplant Recipients is a national database of statistics related to solid organ transplantation - kidney, liver, pancreas, intestine, heart, and lung. The registry covers the full range of transplant activity, from organ donation and waiting list candidates to transplant recipients and survival statistics. Its purpose: to support the development of sound policy, to encourage research on issues of importance to the transplant community, and to facilitate responsible analysis of transplant programs and organ procurement organizations (OPOs).